Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Senseonics Holdings Inc

Start price
Target price
Perf. (%)
€2.55
10.12.21
€10.00
31.12.23
-63.92%
11.06.22

EBIT growth > 30% per year expected
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
High Investments for future growth
buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€7.05
08.12.21
-
08.12.22
-4.99%
12.12.21

Risky Investment
buy
Oncodesign S.A.

Start price
Target price
Perf. (%)
€8.61
08.12.21
€10.00
08.12.22
65.85%
09.12.22

Could be worthwhile Investment >10% per year
Dare Bioscience Inc.

Start price
Target price
Perf. (%)
€2.80
08.12.21
-
08.12.22
-41.43%
10.12.21

Risky Investment
buy
Aldeyra Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.90
07.12.21
-
07.12.22
4.24%
11.12.21

Risky Investment
buy
Merck KGaA

Start price
Target price
Perf. (%)
€218.70
07.12.21
-
07.12.22
-20.85%
08.12.22

buy
Bayer AG

Start price
Target price
Perf. (%)
€43.96
06.12.21
€48.00
12.10.22
12.32%
13.10.22

Could be worthwhile Investment >10% per year
buy
Biofrontera AG

Start price
Target price
Perf. (%)
€1.60
06.12.21
€2.80
06.12.22
-1.25%
07.12.22

Could be worthwhile Investment >10% per year
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€48.36
06.12.21
€60.00
06.12.22
-0.12%
06.12.22

Could be worthwhile Investment >10% per year
buy
Roche Holding AG ADR

Start price
Target price
Perf. (%)
€43.56
06.12.21
€50.00
06.12.22
-12.11%
06.12.22

Could be worthwhile Investment >10% per year
buy
Novartis AG ADR

Start price
Target price
Perf. (%)
€70.80
06.12.21
€90.00
06.12.22
22.32%
06.12.22

Could be worthwhile Investment >10% per year
iBio Inc.

Start price
Target price
Perf. (%)
€15.25
05.12.21
€5.00
05.12.22
-59.08%
03.08.22

Capable Management
Good culture
Valuable balance sheet
Dependend from some customers or products
buy
Bayer AG

Start price
Target price
Perf. (%)
€44.90
05.12.21
€57.00
05.12.22
18.68%
03.02.22

buy
Radius Health Inc.

Start price
Target price
Perf. (%)
€13.05
05.12.21
-
05.12.22
-48.66%
11.12.21

Risky Investment
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.88
05.12.21
-
05.12.22
0.47%
12.12.21

Risky Investment
buy
MorphoSys AG

Start price
Target price
Perf. (%)
€33.45
05.12.21
€40.00
05.12.22
-27.32%
01.03.22

Could be worthwhile Investment >10% per year
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€147.98
05.12.21
-
05.12.22
-23.17%
07.01.22

Could be worthwhile Investment >10% per year
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€42.42
03.12.21
-
03.12.22
7.50%
11.12.21

Risky Investment
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.62
03.12.21
-
03.12.22
0.84%
11.12.21

Could be worthwhile Investment >10% per year
buy
Hybrigenics S.A.

Start price
Target price
Perf. (%)
€0.12
03.12.21
€0.25
03.12.22
-46.60%
04.12.22

Could be worthwhile Investment >10% per year
buy
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€4.62
02.12.21
-
02.12.22
45.82%
12.12.21

Risky Investment
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€3.28
02.12.21
-
02.12.22
-0.61%
11.12.21

Risky Investment
buy
Stoke Therapeutics Inc

Start price
Target price
Perf. (%)
€21.00
02.12.21
€28.00
02.12.22
-67.38%
03.12.22

Could be worthwhile Investment >10% per year
buy
Oncopeptides AB

Start price
Target price
Perf. (%)
€1.02
02.12.21
€1.50
02.12.22
56.67%
03.12.22

Could be worthwhile Investment >10% per year
buy
Theradiag S.A.

Start price
Target price
Perf. (%)
€2.16
02.12.21
€2.80
02.12.22
4.86%
03.12.22

Could be worthwhile Investment >10% per year